Discussions on with Indian govt for expedited approval of COVID-19 vaccine: Pfizer

Earlier in April, Pfizer said that it had offered a not-for-profit price for its vaccine for the government immunisation programme in India and it remains committed to continuing engagement with the government to make the vaccine available in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3aXHZ0w
via IFTTT